Dr Priscilla Leon

Chirurgien urologue

L'essentiel
Carte
Présentation
Horaires
Tarifs

Royan

Jonzac

Rochefort

Saintes

Service d'Urologie et Andrologie du pôle chirurgical royannais
Clinique Pasteur - Urologie

222 Avenue de Rochefort, 17200 Royan

Tarifs et remboursement

Conventionné secteur 2 avec OPTAM-CO

Carte Vitale acceptée

Voir les tarifs

Moyens de paiement

Chèques, espèces et carte bancaire

Expertises et actes

Cancer de la prostate

Cancer de la vessie

Chirurgie de la lithiase urinaire

Chirurgie du prolapsus génital et de l'incontinence urinaire de la femme

Urologie

▾ Voir plus

Carte et informations d'accès

Service d'Urologie et Andrologie du pôle chirurgical royannais
Clinique Pasteur - Urologie

222 Avenue de Rochefort, 17200 Royan

Moyens de transport

Bus - Clinique (ligne 11)

Informations pratiques

Rez-de-chaussée
Entrée accessible
Parking gratuit

Présentation

Le docteur Priscilla Leon vous accueille à son cabinet au sein de la clinique Pasteur à Royan, et ainsi qu'à Rochefort, Saintes (clinique Richelieu) et à Jonzac. Titulaire d'un DESC de chirurgie urologique, DESC de cancérologie et DESC d'andrologie. Titulaire d'un DIU de chirurgie robotique. Titulaire d'un DIU d'urodynamique. Médecin accrédité par l'HAS. Elle fait partie des sociétés savantes suivantes : Depuis 2021 : Membre du sous comité de cancérologie de la vessie de l'association française d'urologie : https://www.urofrance.org/quisommes-nous/afu/afu-organisation/comites/science-et-recherche/comites-scientifiques/cancerologie.html 2019-2021 : Membre du comité de neuro urologie de l'association française d'urologie : https://www.urofrance.org/quisommes-nous/afu/afu-organisation/comites/science-et-recherche/comites-scientifiques/neuro-urologie.html Depuis 2023 : Rédactrice d'Urojonction Depuis 2020 : Membre du comité de Direction médical de la clinique Pasteur, Royan Co rédaction de la revue Urojonction. Membre du comité de formation de l'association française d'urologie : https://www.urofrance.org/quisommes-nous/afu/afu-organisation/comites/enseignement-et-formation/cfc.html Le chirurgien urologue est le spécialiste des appareils urinaire et génital de l'homme et de l'appareil urinaire de la femme. Il dépiste et traite les pathologies liées aux reins, aux voies urinaires, aux glandes surrénales et au système reproducteur masculin (prostate, organes génitaux externes).

▾ Voir plus

Langues parlées

Français

Site web

Voir le site

Diplômes nationaux et universitaires

2017

D.E.S.C. Urologie - Faculté de médecine de Reims

2016

Diplôme d'État de docteur en médecine - Faculté de médecine de Reims

2016

D.E.S.C. Chirurgie générale - Faculté de médecine de Reims

2016

D.E.S.C. Cancérologie - Faculté de médecine de Reims

2016

D.E.S.C. Andrologie - Université de Reims Champagne-Ardenne

Expérience

Depuis 2018

Médecin - Clinique Pasteur Royan - Royan - Urologie

2016 - 2018

Chef de clinique - Centre Hospitalier Universitaire (CHU) de Reims - Reims

Associations

Membre - Association Française d’Urologie (AFU)

Membre - European Association of Urology (EAU)

Membre - Société Interdisciplinaire Francophone d’UroDynamique et de Pelvi-Périnéologie (SIFUD-PP)

Travaux et publications

2024

Urologists have a duty to think about occupational urinary cancers - Article

2023

Prognostic value of programmed death ligand-1 and programmed death-1 expression in patients with upper tract urothelial carcinoma - Article

2023

Outpatient surgery for penile hypospadias in pediatric urology: A monocentric experience with a mean follow-up of 3 years - Article

2023

Efficacy, Safety, and Reoperation-free Survival of Artificial Urinary Sphincter in Non-neurological Male Patients over 75 Years of Age - Article

2023

A prospective descriptive 1-year study in France of all BCG therapy dispensations for non-muscle-invasive bladder cancer - Article

2022

Oncological Outcomes of Distal Ureterectomy for High-Risk Urothelial Carcinoma: A Multicenter Study by The French Bladder Cancer Committee - Article

2022

Impact of radiation therapy on artificial urinary sphincter implantation in male patients: A multicenter study - Article

2022

Guidelines from the cancer committee of the French Association of Urology (CC-AFU) for adequate intravesical instillations of Mitomycin C, Epirubicin, and BCG for non-muscle invasive bladder cancer - Article

2022

Guidelines from the cancer (CC-AFU) and infection disease (CI-AFU) committees of the French Association of Urology for the management of adverse events and complications of BCG - Article

2022

French AFU Cancer Committee Guidelines - Update 2022-2024: Non-muscle-invasive bladder cancer (NMIBC) - Article

2022

French AFU Cancer Committee Guidelines - Update 2022-2024: Muscle-Invasive Bladder Cancer (MIBC) - Article

2022

French AFU Cancer Committee Guidelines - Update 2022-2024: Upper urinary tract urothelial cancer (UTUC) - Article

2022

Comment faire sans les bandelettes de renfort vaginal ? How to manage pelvic organ prolapse without vaginal mesh repair? - Article

2022

Artificial urinary sphincter in patients with urinary incontinence after High Intensity Focused ultrasound - Article

2022

A study of the immunohistochemical profile of bladder cancer in neuro-urological patients by the French Association of Urology - Article

2022

A prospective descriptive 1-year study in France of all BCG therapy dispensations for non-muscle-invasive bladder cancer - Article

2021

Évolution du score USP et IPSS après appareillage du syndrome d’apnées du sommeil par pression positive continue nocturne - Article

2021

Transcorporal vs. bulbar artifcial urinary sphincter implantation in male patients with fragile urethra - Article

2021

Prevalence and Risk Factors of Artificial Urinary Sphincter Revision in Non-Neurological Male Patients - Article

2021

La désescalade dans les tumeurs de vessie n’infiltrant pas le muscle de bas grade. Expert opinion: De-escalation in support in NMIBC - Article

2021

Impact of positive surgical margins on prostate cancer prognosis - Article

2021

Impact of COVID-19 pandemic on functional urology procedures in France: a prospective study - Article

2021

Functional results and satisfaction in 44 patients after implantation of a NS3-type sacral neurostimulator for refractory idiopathic overactive bladder followed at 43 months, single-center series - Article

2021

Bayesian predictive model to assess BRCA2 mutational status according to clinical history: Early onset, metastatic phenotype or family history of breast/ovary cancer - Article

2020

Testosterone replacement therapy (TRT) and prostate cancer: An updated systematic review with a focus on previous or active localized prostate cancer. - Article

2020

Interest of reTURB for pTa high grade bladder urothelial carcinoma - Article

2020

Impact of antiplatelet and anticoagulant treatments on bleeding complications in patients treated with HoLEP - Article

2020

Factors affecting guideline adherence in the initial treatment of non-muscle invasive bladder cancer: Retrospective study in a French peripheral hospital - Article

2019

Long-term functional outcomes of augmentation cystoplasty in adult spina bifida patients: A single-center experience in a multidisciplinary team - Article

2018

Rare neuroendocrine tumor decades after bladder exstrophy repair with enterocystoplasty - Article

2018

Male neurogenic stress urinary incontinence treated by artificial urinary sphincter AMS 800™ (Boston Scientific, Boston, USA): Very long-term results (>25 years) - Article

2018

Diagnosis and treatment of inguinal hernia of the bladder: a systematic review of the past 10 years - Article

2018

Complications of non-continent cutaneous urinary diversion in adults with spinal cord injury: a retrospective study - Article

2018

Comparison of cell cycle progression (CCP) score to two IHC markers (PTEN and Ki-67) for predicting outcome in prostate cancer after radical prostatectomy - Article

2018

Comment l’urologue et son réseau de soin peuvent prendre en charge la toxicité des immunothérapies ? Application aux toxicités digestives - Article

2017

Stress urinary incontinence in female neurological patients: long-term functional outcomes after artificial urinary sphincter (AMS 800TM) implantation - Article

2017

Prevalence and diversity of management of prostate cancer patients classified as low risk using D'Amico group or Cancer of the Prostate Risk Assessment (CAPRA) score: A French multicenter study - Article

2017

Correlation of genetic and cytogenetic alterations in pathological aggressiveness urothelial carcinoma of the bladder: Performance of BCA-1, a mini-array comparative genomic hybridisation-based test - Article

2016

The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery - Article

2016

Relevance of repeat transurethral resection of the bladder for high grade pta bladder cancer: a review - Article

2016

Apparent diffusion coefficient value is a strong predictor of unsuspected aggressiveness of prostate cancer before radical prostatectomy - Article

2015

Trends in the placement of penile prostheses over the last 17 years in France. - Article

2015

The role of cystectomy in elderly patients: a multicentre analysis. - Article

2015

Surgical landscape of radical cystectomy for bladder cancer in France over the last 10 years - Article

2015

Prostate cancer: what about reproducibility of decision made at multidisciplinary team management? - Article

2015

Multiparametric magnetic resonance imaging predicts postoperative pathology but misses aggressive prostate cancers as assessed by cell cycle progression score - Article

2015

Long-term functional outcomes after artificial urinary sphincter implantation in men with stress urinary incontinence - Article

2015

Long term functional outcomes obtained after implantation of urinary sphincter in a population of male - Article

2015

Influence of statin use on clinicopathological characteristics of localized prostate cancer and outcomes obtained after radical prostatectomy: a single center study - Article

2015

Des taux circulants de testostérone libre et biodisponible faibles sont-ils prédictifs de tumeurs de haut grade chez les patients subissant une prostatectomie radicale pour cancer localisé de la prostate ? - Thèse

2015

Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old - Article

2015

Accuracy of the prostate health index versus the urinary prostate cancer antigen 3 score to predict overall and significant prostate cancer at initial biopsy - Article

2015

A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma - Article

2014

The impact of obesity on renal function at one year after kidney transplantation: single-center experience - Article

2014

The impact of obesity on renal function at one year after kidney transplantation: single-center experience - Article

2014

Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studies - Article

2014

Local consultations by specialists in urology: an answer to patients' expectations and dwindling physician numbers? - Article

2014

Impact of histological variants on the outcomes of nonmuscle invasive bladder cancer after transurethral resection. - Article

2014

Epidemiology and risk factors of upper urinary tract tumors: literature review for the yearly scientific report of the French National Association of Urology - Article

2014

Botulinum toxin injections in the management of non-neurogenic overactive bladders in children - Article

2013

ZSI 375 artificial urinary sphincter for male urinary incontinence: a preliminary study - Article

2013

Influence of plasmatic testosterone during natural history of prostate cancer: a review - Article

2012

Andropause (androgen deficiency of the aging male): diagnosis and management - Article

Horaires et coordonnées

Horaires d'ouverture

Contact d'urgence

En cas d'urgence, contactez le 15 (Samu)

Coordonnées

05 46 22 24 67

Tarifs

Première consultation 55 € à 75 €
Consultation de suivi 30 € à 45 €
Bilan urodynamique160 €

Ces honoraires vous sont communiqués à titre indicatif par le soignant. Ils peuvent varier selon le type de soins finalement réalisés en cabinet, le nombre de consultations et les actes additionnels nécessaires. En cas de dépassement des tarifs, le soignant doit en avertir préalablement le patient.

Informations légales

Numéro RPPS

10100807261

Partager un problème avec un profil